AlphaFlo

AlphaFlo® is a liquid, acellular, canine amniotic tissue allograft comprised of amnion intended to supplement and protect tissues.

12/19/2025

AlphaFlo® is a liquid, cryopreserved, canine amniotic tissue allograft designed to supplement and protect tissues. Its use may be minimally invasive, safe, and offer a morbidity profile comparable to or better than existing modalities while supporting consistent clinical outcomes.

Unlike autologous therapies that require culturing or harvesting, AlphaFlo® is readily available and eliminates preparation delays. It also avoids the variability seen with other modalities.

Because AlphaFlo® is cryopreserved rather than lyophilized, key proteins and bioactive components are better maintained, contributing to product consistency, reproducibility across cases and improved clinical outcomes.

Curious about how AlphaFlo® might support your practice? Learn more: https://alphaflocanine.com/

12/16/2025

At 17, Cody’s mobility returned after setbacks that included seizures and loss of limb use.
His owner shared, “Now he is walking and supporting himself... wagging his tail and excited about treats and dinner.”

Cody’s progress is a testament to thoughtful care, consistency, and veterinary support. Want to see how veterinarians are using AlphaFlo® to support canine athletes and recovery cases? Learn more: https://alphaflocanine.com/

12/15/2025

In this comparative case, 14 dogs underwent TPLO procedures. Seven received AlphaFlo® intra-articularly at closure while the other seven did not.

This observational study explores AlphaFlo®’s integration during orthopedic surgery and the clinical outcomes observed. Learn more: https://alphaflocanine.com/tibial-plateau-leveling-osteotomy-case-study/

12/12/2025

Veterinarians across the country are sharing their clinical experiences using AlphaFlo®. From diagnostics to follow-up care, these insights reflect how AlphaFlo® is being integrated into real-world practices to support tissue health.

Curious about what clinicians are seeing? Explore more perspectives: https://alphaflocanine.com/

12/11/2025

Kleio’s care began with a clear diagnosis and clinical plan, giving her a path back to competition. The client shared, “Kleio is on her way to competing competitively again in North America Diving Dogs.”

Her veterinary team supported her through a PSOAS condition using a thorough and individualized approach. Want to see how veterinarians are using AlphaFlo® to support canine athletes and recovery cases? Learn more: https://alphaflocanine.com/

12/10/2025

In this new blog, Dr. Mark Besancon outlines how his approach evolved from viewing regenerative therapies as a secondary option to making AlphaFlo® a foundational part of care.

He writes, “As outcomes improved and cases responded more quickly and more completely, it became clear that this tool belongs at the front of the treatment plan.”

Read now: https://alphaflocanine.com/alphaflo-veterinarian-clinical-approach-regenerative-therapy/

12/09/2025

AlphaFlo® was proud to connect with veterinary surgeons and clinicians at ACVS in Seattle. From regenerative applications to peer conversations, we’re grateful for the opportunity to share how AlphaFlo® is supporting practices nationwide.

Want more info on integrating AlphaFlo® into your workflow? Learn more: https://alphaflocanine.com/

12/08/2025

Gidget’s family shared how AlphaFlo® became part of her care as she aged. “We are so happy to have AlphaFlo® Canine to extend the quality of our senior dog’s life.”

Stories like hers continue to highlight how veterinarians are supporting senior patients with regenerative options. Learn more: https://alphaflocanine.com/

12/05/2025

A three-year-old hound mix with a chronic skin lesion underwent 12 rounds of laser therapy with minimal progress. After clinical reevaluation, AlphaFlo® was implanted subcutaneously around the margin of the lesion.

Explore the case progression and veterinarian’s decision-making process: https://alphaflocanine.com/case-study-acral-lick-dermatitis/

12/04/2025

Dr. Mark Besancon is speaking at Fetch DVM360 in Long Beach on the clinical applications of amniotic tissue allografts. If you're attending, make plans to join this CE session focused on regenerative tools for veterinary practice.

🗓 Saturday December 6
🕝 2:30 to 3:30 PM
📍 Room 101A

12/03/2025

Watch shipments of AlphaFlo® and RenoVō® in action as they head out to veterinary clinics nationwide!

Each package contains an acellular allograft derived from amniotic tissues, carefully cryopreserved and delivered on dry ice to support tissue health in dogs and horses.

This is how we help make regenerative options accessible and ready when veterinarians need them

Want to learn more? Learn more: https://alphaflocanine.com/

Address

308 E FM 1830, Building 2 Suite A
Argyle, TX
76226

Telephone

(501)7085000

Website

http://www.Alphaflocanine.com/

Alerts

Be the first to know and let us send you an email when AlphaFlo posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.